KINEVAC (Bracco Diagnostics Inc.)


Welcome to the PulseAid listing for the KINEVAC drug offered from Bracco Diagnostics Inc.. This Cholecystokinin [Chemical/Ingredient],Cholecystokinin Analog [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Bracco Diagnostics Inc.
NON-PROPRIETARY NAME: sincalide
SUBSTANCE NAME: SINCALIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cholecystokinin [Chemical/Ingredient],Cholecystokinin Analog [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1976-07-21
END MARKETING DATE: 0000-00-00


KINEVAC HUMAN PRESCRIPTION DRUG Details:

Item DescriptionKINEVAC from Bracco Diagnostics Inc.
LABELER NAME: Bracco Diagnostics Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 5(ug/5mL)
START MARKETING DATE: 1976-07-21
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0270-0556_0faaa9fb-f1b3-a112-2d9e-84db92e3e4ad
PRODUCT NDC: 0270-0556
APPLICATION NUMBER: NDA017697

Other SINCALIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AnazaoHealth CorporationSIncalide
Bracco Diagnostics Inc.KINEVAC